EODData

MEMBERSHIP REGISTER LOG IN

FRA, 07X: ANNOVIS BIO INC. DL-0001

04 Sep 2025
LAST:

1.928

CHANGE:
 0.04		OPEN:
1.928		HIGH:
1.928		ASK:
0.000		VOLUME:
300
CHG(%):
2.23		PREV:
1.972		LOW:
1.928		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 251.9281.9281.9281.928300
03 Sep 251.9721.9721.9721.972300
02 Sep 251.9461.9461.9461.946300
01 Sep 251.9401.9401.9401.940300
29 Aug 251.9562.0201.9562.020300
28 Aug 251.9941.9941.9941.994500
27 Aug 252.0752.0752.0752.075500
26 Aug 251.9221.9221.9221.922500
25 Aug 251.9961.9961.9961.996500
22 Aug 252.0252.0252.0252.025500

COMPANY PROFILE

Name:ANNOVIS BIO INC. DL-0001
About:Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:101 Lindenwood Drive, Malvern, PA, United States, 19355
Website:https://www.annovisbio.com
ISIN:US03615A1088
LEI:549300IFBVI51FN3NJ32

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.96
MA10:1.98
MA20:2.12
MA50:2.17
MA100:2.01
MA200:2.77
STO9:3.92
STO14:1.55
RSI14:26.08
WPR14:-98.45
MTM14:-0.38
ROC14:-0.17
ATR:0.06
Week High:2.02
Week Low:1.93
Month High:2.40
Month Low:1.92
Year High:9.26
Year Low:1.06
Volatility:55.46